Coherus Biosciences | SCHULD





SCHULD Veränderung Datum
AbbVie USD 1000K 70.48B 2025-09
Acadia Pharmaceuticals USD 56.29M 1.36M 2025-06
Akebia Therapeutics USD 46.51M 7.82M 2025-03
ALKERMES USD 72.68M 293.32M 2025-06
Alnylam Pharmaceuticals USD 1.3B 271.5M 2025-06
Amarin USD 0 0 2025-03
Amgen USD 54.59B 1.62B 2025-09
Baxter International USD 9.73B 584M 2025-06
Biogen USD 6.29B 1.7M 2025-12
BioMarin Pharmaceutical USD 603.87M 8.22M 2025-06
Bristol-Myers Squibb USD 51.04B 112M 2025-09
Coherus Biosciences USD 294.92M 1.25M 2025-03
Eli Lilly USD 42.51B 2.6B 2025-09
Fujifilm JPY 922.82B 236.91B 2025-09
Gilead Sciences USD 24.94B 5M 2025-09
Ironwood Pharmaceuticals USD 583.99M 14.83M 2024-12
Merck USD 41.37B 5.97B 2025-09
Myriad Genetics USD 59.3M 19.7M 2025-03
Pacira USD 376.72M 203.77M 2025-09
Perrigo USD 3.65B 454.7M 2025-06
Pfizer USD 60.85B 78M 2025-09
PTC Therapeutics USD 286.32M 306K 2025-09
Regeneron Pharmaceuticals USD 2.71B 400K 2025-09
Sarepta Therapeutics USD 1.35B 215.59M 2025-06
Teva Pharmaceutical Industries USD 17.07B 450M 2025-09
Vertex Pharmaceuticals USD 1.53B 121.7M 2025-06
Xencor USD 67.93M 86.45M 2025-06
Zoetis USD 6.79B 1.11B 2025-06


Coherus Biosciences SCHULD - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.